Volume 19 (2024)
Volume 18 (2023)
Volume 17 (2022)
Volume 16 (2021)
Volume 15 (2020)
Volume 14 (2019)
Volume 13 (2018)
Volume 12 (2017)
Volume 11 (2016)
Volume 10 (2015)
Volume 9 (2014)
Volume 8 (2013)
Volume 7 (2012)
Volume 6 (2011)
Volume 5 (2010)
Volume 4 (2009)
Volume 3 (2008)
Volume 2 (2007)
Volume 1 (2006)
No Evidence of the Th1 to Th2 Cytokine Shift during the Course of HIV Infection

Safyeh Soufian; Arezoo Aghakhani; Minoo Mohraz; Mohammad Banifazl; Ali Eslamifar; Zahra Boland-Ghamat; Akbar Khadem-Sadegh; Amitis Ramezani

Volume 7, Issue 2 , April 2012, , Pages 80-85

Abstract
  Background and Objectives: Infection with human immunodeficiency virus (HIV) results in dysregulation of the cytokine profile. A switch from a T helper 1 (Th1) to a Th2 cytokine has been proposed as an important factor in progression of HIV infection to AIDS. The aim of the present study was to assess ...  Read More

Frequency of Human T-Cell Lymphotropic Virus (HTLV) Type 1 and 2 Infection in HIV Infected Patients

Amitis Ramezani; Arezoo Aghakhani; Mohammad Banifazl; Zahra Boland-Ghamat; Maryam Foroughi; Latif Gachkar; Akbar hadem-Sadegh; Minoo Mohraz

Volume 7, Issue 1 , January 2012, , Pages 9-13

Abstract
  Background and Objectives: Human T-cell lymphotropic viruses (HTLV) type 1 and 2 are retroviruses that share the same routes of transmission as human immunodeficiency virus (HIV). As a consequence of epidemiologic similarities, HIV and HTLV-1/2 co-infection is frequent. Due to the limited data, this ...  Read More

Significance of Hepatitis B Core Antibody as the Only Marker of Hepatitis B Virus Infection in High Risk Patients

Arezoo Aghakhani; Amitis Ramezani; Minoo Mohraz; Mohammad Banifazl; Ali Eslamifar

Volume 4, Issue 2 , April 2009, , Pages 80-84

Abstract
    Background and Objective: Presence of hepatitis B core antibody (anti-HBc) in the absence of hepatitis B surface antigen (HBsAg) and hepatitis B surface antibody (anti-HBs) is defined, as isolated anti-HBc. little is known about the clinical significance of the isolated anti-HBc in hepatitis ...  Read More

Metabolic Abnormalities in HIV-Positive Patients Receiving Highly Active Antiretroviral Therapy

Amitis Ramezani; Minoo Mohraz; Mohammad Banifazl; Latif Gachkar; Sara Jam; Ali Eslamifar; Farhad Yaghmaie; Kambiz Nemati; Arezoo Aghakhani

Volume 2, Issue 4 , September 2007, , Pages 154-158

Abstract
  Background and Objective: Dyslipidemia has become a common problem in human immunodeficiency virus (HIV) disease, especially in patients on combination antiretroviral therapy. In this study we aimed to determine the prevalence of dyslipidemia and metabolic abnormalities in 2 groups of HIV infected patients ...  Read More